4//SEC Filing
LIPOSCIENCE INC 4
Accession 0001209191-13-005166
CIK 0001168197operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:14 PM ET
Size
7.3 KB
Accession
0001209191-13-005166
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
SANDERS CHARLES A
Director
Transactions
- Conversion
Series E Convertible Preferred Stock
2013-01-30−2,298→ 0 total→ Common Stock (1,114 underlying) - Conversion
Common Stock
2013-01-30+1,114→ 9,844 total
Footnotes (3)
- [F1]Represents shares received upon conversion of shares of Series E convertible preferred stock.
- [F2]Effective immediately prior to the closing of the issuer's initial public offering of its common stock, each share of Series E convertible preferred stock automatically converted into 0.485 shares of common stock. The convertible preferred stock had no expiration date.
- [F3]The Series E Convertible Preferred Stock converted into common stock on a 0.485-for-1 basis and had no expiration date.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168197
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:14 PM ET
- Size
- 7.3 KB